Latest Breaking News On - Bristol myers squibbmedia - Page 1 : vimarsana.com

Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung…

PRINCETON, N.J. (BUSINESS WIRE) Mar 28, 2024

United statesBristol myers squibbAbderrahim oukessouBristol myers squibbmediaExchange commissionRegulatory agencyEuropean commissionTrial evaluatingMeets primary endpointProgression free survivalMutated locally advancedMetastatic non small cell lungMyers squibbBlinded independent central reviewBristol myersPrescription drug user fee act

Bristol Myers Squibb Presents New Data at ASH 2023 Demonstrating Clinical Benefit Across B-cell Malignancies with Breyanzi as a Second-Line Treatment in High-Risk Follicular Lymphoma and in Relapsed or Refractory Chronic Lymphocytic Leukemia

PRINCETON, N.J. (BUSINESS WIRE) Dec 10, 2023

United statesFranck morschhauserBristol myers squibbmediaBristol myers squibbAnne kerberTanya siddiqiExchange commissionInternational workshop on chronic lymphocytic leukemiaCity of hope national medical centerDepartment of hematologyAmerican society of hematologyHead of late clinical developmentDrug administrationMyers squibbOral presentationAnnual meeting

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
valdostadailytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from valdostadailytimes.com Daily Mail and Mail on Sunday newspapers.

United statesChris boernerCharles baumBristol myers squibbmediaGiovanni caforioSamit hirawatBristol myers squibbEvercore incDrug administrationMeagher flomHead of global drug developmentKirkland ellisSecurities exchangeMorgan stanley coCenterview partnersMirati therapeutics inc

Bristol Myers Squibb Receives European Commission Approval of CAMZYOS® (mavacamten), for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)

PRINCETON, N.J. (BUSINESS WIRE) Jun 26, 2023

South koreaUnited kingdomUnited statesBristol myers squibbBristol myers squibbmediaSamit hirawatIacopo olivottoUniversity of florenceEuropean commissionExchange commissionYork heart associationEuropean unionMyers squibbNew york heart associationBristol myersMeyer children

Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights

Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC 2022 Highlights
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Comunidad autonoma de catalunaBristol myers squibbmediaBristol myers squibbEuropean society of cardiology congressMyers squibbInvestor eventEuropean societyCardiology congressBusiness wire